P

Inventor

KUMAR RAVINDRA

US163 patents
⚠️ This page may combine multiple inventors who share the name “KUMAR RAVINDRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ACCELERON PHARMA INC

31 patents
US8343933B2Jan 1, 2013

Variants derived from ActRIIB and uses therefor

ACCELERON PHARMA INC91 citations99
US7842663B2Nov 30, 2010

Variants derived from ActRIIB and uses therefor

ACCELERON PHARMA INC135 citations99
US8361957B2Jan 29, 2013

Isolated GDF trap polypeptide

ACCELERON PHARMA INC42 citations98
US10722558B2Jul 28, 2020

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC15 citations94
US10695405B2Jun 30, 2020

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC13 citations94
US10377996B2Aug 13, 2019

Methods of identifying ActRIIB variants

ACCELERON PHARMA INC24 citations94
US10358633B2Jul 23, 2019

Method for producing an ActRIIB-Fc fusion polypeptide

ACCELERON PHARMA INC15 citations94
US10259861B2Apr 16, 2019

Variants derived from ActRIIB and uses therefor

ACCELERON PHARMA INC22 citations94
US10131700B2Nov 20, 2018

Methods for treating refractory anemia with ringed sideroblasts

ACCELERON PHARMA INC20 citations94
US9932379B2Apr 3, 2018

Isolated nucleotide sequences encoding GDF traps

ACCELERON PHARMA INC19 citations94
US9745559B2Aug 29, 2017

Method for decreasing the body fat content in a subject by administering an ActRIIB protein

ACCELERON PHARMA INC22 citations94
US9399669B2Jul 26, 2016

Variants derived from ActRIIB

ACCELERON PHARMA INC27 citations94
US9181533B2Nov 10, 2015

Truncated ACTRIIB-FC fusion protein

ACCELERON PHARMA INC26 citations93
US9809637B2Nov 7, 2017

Transforming growth factor beta receptor II fusion polypeptides

ACCELERON PHARMA INC19 citations92
US9505813B2Nov 29, 2016

Use of GDF traps to treat anemia

ACCELERON PHARMA INC20 citations92
US9439945B2Sep 13, 2016

Isolated nucleotide sequences encoding GDF traps

ACCELERON PHARMA INC18 citations92
US11622992B2Apr 11, 2023

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC3 citations84
US11219666B2Jan 11, 2022

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC5 citations84
US11065303B2Jul 20, 2021

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC6 citations84
US11028145B2Jun 8, 2021

ALK7:actriib heteromultimers and uses thereof

ACCELERON PHARMA INC4 citations84
US10973880B2Apr 13, 2021

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC7 citations84
US10946067B2Mar 16, 2021

Compositions and methods for treating pulmonary hypertension

ACCELERON PHARMA INC6 citations84
US10889626B2Jan 12, 2021

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

ACCELERON PHARMA INC4 citations84
US10829532B2Nov 10, 2020

Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

ACCELERON PHARMA INC4 citations84
US10738098B2Aug 11, 2020

ALK4:ActRIIB heteromultimers and uses thereof

ACCELERON PHARMA INC6 citations84
US10689427B2Jun 23, 2020

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

ACCELERON PHARMA INC7 citations84
US10358476B2Jul 23, 2019

Single arm type I and type II receptor fusion proteins and uses thereof

ACCELERON PHARMA INC12 citations84
US10307455B2Jun 4, 2019

Activin type 2 receptor antibodies

ACCELERON PHARMA INC5 citations84
US10227393B2Mar 12, 2019

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

ACCELERON PHARMA INC9 citations84
US10023621B2Jul 17, 2018

Follistatin-related fusion proteins

ACCELERON PHARMA INC5 citations84
US9790284B2Oct 17, 2017

Methods for increasing thermogenic adipocytes

ACCELERON PHARMA INC5 citations84

SEEHRA JASBIR

6 patents

KNOPF JOHN

5 patents

GENETICS INST

5 patents

NETAPP INC

2 patents

GENETICS INST LLC

1 patent

Showing the top 50 of 163 patents by PatentIndex Score.